| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations. | J Clin Invest | 2015 | 1.76 |
| 2 | Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity. | J Clin Invest | 2017 | 0.75 |